Benevir Biopharm, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 9
Rang # Quantité totale PI 171 247
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 467 807
Parent Janssen Biotech, Inc.

Brevets

Marques

5 0
2 0
2 0
0
 
Dernier brevet 2022 - Oncolytic herpes simplex virus a...
Premier brevet 2012 - Oncolytic herpes simplex virus a...

Derniers inventions, produits et services

2021 Invention Oncolytic herpes simplex virus and therapeutic uses thereof. The present invention relates to va...
2019 Invention Oncolytic herpes simplex virus and therapeutic uses thereof. The present invention relates to var...
2015 Invention Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof. The present inventi...
Invention Exogenous tap inhibitor "armed" oncolytic viruses and therapeutic uses thereof. The present inven...
2012 Invention Oncolytic herpes simplex virus and therapeutic uses thereof. The disclosure relates to variants o...